Serum Institute of India Pvt. Ltd., often referred to as Serum Institute, is a leading biotechnology company headquartered in Pune, India. Established in 1966, it has grown to become the world's largest producer of vaccines by volume, significantly impacting global health. The company primarily operates in the biopharmaceutical industry, focusing on the development, production, and distribution of vaccines and immunobiologicals. Serum Institute's core products include vaccines for diseases such as measles, polio, and hepatitis, as well as innovative solutions for emerging health challenges. Its commitment to affordability and accessibility sets it apart in the market. With a robust presence in over 170 countries, Serum Institute has achieved notable milestones, including partnerships for COVID-19 vaccine production, solidifying its position as a key player in global immunisation efforts.
How does Serum Institute of India Pvt. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Serum Institute of India Pvt. Ltd.'s score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Serum Institute of India Pvt. Ltd. does not report specific carbon emissions figures, indicating a lack of publicly disclosed emissions data. The company is a current subsidiary and may inherit climate-related commitments and data from its parent organisation, but no specific details are provided regarding emissions or reduction targets. Serum Institute of India Pvt. Ltd. has not outlined any specific reduction initiatives or targets, nor does it appear to participate in recognised climate pledges such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, where sustainability and carbon footprint reduction are increasingly critical, Serum Institute of India Pvt. Ltd. may need to enhance its transparency and commitment to climate action to align with industry standards and stakeholder expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Serum Institute of India Pvt. Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.